Medically reviewed by a licensed healthcare professional. Last updated April 2026.

Searching for semaglutide before and after results is one of the first things people do when considering GLP-1 medication. I get it. You want to know what is realistic before you commit to weekly injections and a monthly bill. Here is what the data actually shows, month by month, with none of the cherry-picked transformation photos that dominate social media.

:::takeaway

  • The STEP 1 trial showed average weight loss of 14.9% of body weight over 68 weeks at the 2.4 mg dose.
  • For a 250-pound person, that translates to roughly 37 pounds over 16 months.
  • Most weight loss happens between months 2 and 9. After that, weight stabilizes at a new baseline.
  • About 40% of weight lost comes from lean mass, making protein and resistance training critical.
  • Roughly one-third of patients exceeded the average by a significant margin.

:::

What the Clinical Trials Show

The STEP 1 trial is the gold standard for semaglutide weight loss data. Here are the numbers:

  • 1,961 participants with obesity or overweight
  • 68 weeks of treatment
  • Average weight loss: 14.9% of body weight (vs 2.4% for placebo)
  • Dose: 2.4 mg weekly (Wegovy maintenance dose)

For context, here is what 14.9% means at different starting weights:

Starting Weight 14.9% Loss Approximate Final Weight
200 lbs 30 lbs 170 lbs
225 lbs 34 lbs 191 lbs
250 lbs 37 lbs 213 lbs
275 lbs 41 lbs 234 lbs
300 lbs 45 lbs 255 lbs

But averages do not tell the whole story. The distribution of results in STEP 1 looked like this:

  • 86% of participants lost at least 5% of body weight
  • 69% lost at least 10%
  • 50% lost at least 15%
  • 32% lost 20% or more

So roughly one-third of patients exceeded the average by a significant margin, while about 14% saw less than 5% loss.

Month-by-Month Timeline

Here is what to realistically expect from semaglutide, based on the clinical trial dose escalation schedule combined with real-world patient data.

Month 1 (Weeks 1-4)

Expected loss: 1 to 2% of body weight (2-5 lbs at 250 lbs)

You start at 0.25 mg, which is one-tenth of the maintenance dose. The purpose is to let your gut adjust, not to cause dramatic weight loss. What you will notice:

  • Slightly reduced appetite, especially later in the day
  • You might feel full faster at meals
  • Some patients notice nothing at this dose
  • Mild nausea is possible but often minimal

What is happening internally: semaglutide is slowing gastric emptying, increasing satiety signals in the brain, and beginning to shift your relationship with food. This foundation matters more than the scale shows.

Month 2 (Weeks 5-8)

Expected loss: 3 to 5% of body weight cumulative (7-12 lbs at 250 lbs)

At week 5 you move to 0.5 mg. This is where most patients feel the appetite suppression kick in. You are eating less without white-knuckling it. Food is less interesting. You might walk past the kitchen without grabbing a snack for the first time in years.

Month 3 (Weeks 9-12)

Expected loss: 5 to 7% of body weight cumulative (12-17 lbs at 250 lbs)

You are now at 1 mg. This is a dose where significant metabolic effects are happening. Your clothes start fitting differently. People who see you regularly might comment. The scale is moving consistently. Side effects from the dose increases are becoming more predictable and manageable.

Blood pressure and blood sugar markers may show improvement in lab work. This is typically when the "before and after" difference starts becoming apparent.

Month 4 (Weeks 13-16)

Expected loss: 7 to 9% of body weight cumulative (17-22 lbs at 250 lbs)

You reach 1.7 mg and are approaching the full maintenance dose. Weight loss is consistent at roughly 1 to 1.5 pounds per week. Body composition changes become more noticeable. Waist circumference typically decreases faster than the scale might suggest.

Month 6 (Weeks 21-24)

Expected loss: 10 to 13% of body weight cumulative (25-32 lbs at 250 lbs)

By month 5 you hit the full maintenance dose of 2.4 mg. This is where the transformation becomes very visible. Dramatic changes in face shape, neck, and midsection are common. Many patients have dropped 2 or more clothing sizes. This is the point where most "before and after" photos capture the biggest visual difference.

Month 9 (Weeks 33-36)

Expected loss: 13 to 15% of body weight cumulative (32-37 lbs at 250 lbs)

Weight loss begins to decelerate. You are approaching your body's new equilibrium point on semaglutide. Losing 1 pound per week or less is normal at this stage and does not indicate a problem.

Month 12+ (Weeks 49-52)

Expected loss: 14 to 16% of body weight cumulative (35-40 lbs at 250 lbs)

Most patients have reached or are near their maximum weight loss. The STEP 5 trial confirmed that weight loss at 2 years (15.2%) was nearly identical to weight loss at 1 year, meaning the results hold steady with continued use.

The Body Composition Question

One of the most important aspects of semaglutide weight loss is what kind of weight you are losing. Research from the STEP trials found:

  • Approximately 60% of weight lost was fat mass
  • Approximately 40% was lean mass (including muscle)

This ratio is concerning and is one of the most valid criticisms of GLP-1 medications for weight loss. Losing 40% of weight from lean mass can lead to:

  • Decreased metabolism
  • Reduced strength and physical function
  • "Skinny fat" appearance despite lower body weight
  • Increased risk of sarcopenia, especially in older adults

How to Preserve Muscle on Semaglutide

  • High protein intake: Consume at least 0.7 to 1.0 grams of protein per pound of your goal body weight daily. This is the single most important factor.
  • Resistance training: Lift weights or do bodyweight exercises at least 2 to 3 times per week. This sends a signal to your body to preserve muscle.
  • Adequate calories: While semaglutide reduces appetite, eating too little (below 1,200 calories) accelerates muscle loss. Work with a dietitian to find the right balance.
  • Creatine supplementation: Some providers recommend creatine monohydrate (3 to 5 grams daily) to support muscle preservation during weight loss.

:::tip

Protein is non-negotiable on semaglutide. Even when you are not hungry, aim for at least 80-100 grams per day. Protein shakes, Greek yogurt, and lean meats are your best friends during treatment.

:::

Factors That Affect Your Results

Not everyone loses the same amount. Clinical trials report averages, but individual variation is significant.

Factors associated with greater weight loss:

  • Higher starting BMI (more total pounds lost, similar percentage)
  • Better adherence to dietary changes, especially high-protein diets
  • Consistent physical activity, particularly resistance training
  • Reaching and maintaining the 2.4 mg dose
  • No prior GLP-1 medication use

Factors associated with less weight loss:

  • Type 2 diabetes (insulin resistance blunts some weight loss effect)
  • Concurrent medications that promote weight gain (certain antidepressants, antipsychotics, insulin)
  • Inconsistent dosing or missed injections
  • Very low starting BMI (less total weight to lose)
  • Prior bariatric surgery

If semaglutide is not working well for you after 3 to 4 months at the maintenance dose, your provider may recommend switching to tirzepatide, which targets an additional receptor. Compare Zepbound vs Wegovy to understand the differences.

:::warning

Compounded GLP-1 medications are not FDA-approved. While legal during FDA-recognized drug shortages, they do not undergo the same rigorous testing as brand-name drugs. Always verify your provider uses a licensed 503A or 503B compounding pharmacy.

:::

What Happens After You Stop

This is the part nobody wants to hear, but you need to: most patients regain weight after stopping semaglutide.

The STEP 1 extension study followed patients for one year after they stopped the medication. On average, participants regained about two-thirds of the weight they had lost. Their appetite returned, cravings came back, and the metabolic benefits faded.

This does not mean semaglutide is a failure. It means obesity is a chronic condition that often requires ongoing treatment, just like blood pressure medication or insulin for diabetes. Many providers now frame GLP-1 therapy as long-term or indefinite treatment rather than a short-term intervention.

Getting Started

If you are ready to start semaglutide, here are your options:

Our weight loss calculator can also give you a personalized estimate of your expected results based on clinical trial data and your starting weight.

:::info

GLP-1 medications require a prescription and ongoing medical supervision. Always work with a licensed healthcare provider and verify that any telehealth platform or clinic uses board-certified clinicians and accredited pharmacies.

:::

Sources

  1. Wilding, J.P.H., et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." STEP 1. *New England Journal of Medicine*, 2021.
  2. Wilding, J.P.H., et al. "Weight Regain and Cardiometabolic Effects after Withdrawal of Semaglutide." STEP 1 Extension. *Diabetes, Obesity and Metabolism*, 2022.
  3. Jastreboff, A.M., et al. "Semaglutide 2.4 mg: Two-Year Efficacy and Safety." STEP 5. *Nature Medicine*, 2023.